Protagonist Therapeutics Inc (PTGX)
30.41
-0.13
(-0.43%)
USD |
NASDAQ |
May 24, 16:00
30.44
+0.03
(+0.10%)
After-Hours: 20:00
Protagonist Therapeutics EBITDA Margin (Quarterly)
EBITDA Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EBITDA Margin (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | -- |
December 31, 2023 | -- |
September 30, 2023 | -- |
June 30, 2023 | -- |
March 31, 2023 | -- |
December 31, 2022 | -- |
September 30, 2022 | -- |
June 30, 2022 | -- |
March 31, 2022 | -- |
December 31, 2021 | -- |
September 30, 2021 | -- |
June 30, 2021 | -- |
March 31, 2021 | -- |
December 31, 2020 | -- |
Date | Value |
---|---|
September 30, 2020 | -- |
June 30, 2020 | -- |
March 31, 2020 | -- |
December 31, 2019 | -- |
September 30, 2019 | -- |
June 30, 2019 | -- |
March 31, 2019 | -- |
December 31, 2018 | -- |
September 30, 2018 | -- |
June 30, 2018 | -- |
March 31, 2018 | -- |
December 31, 2017 | -- |
September 30, 2017 | -- |
EBITDA Margin Definition
EBITDA Margin (TTM) is trailing twelve month earnings before interest, taxes, depreciation and amortization divided by trailing twelve month net sales.